101 to News@lemmy.worldEnglish • 7 months agoSEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial.www.sec.govmessage-square0fedilinkarrow-up140arrow-down11
arrow-up139arrow-down1external-linkSEC Charges Cassava Sciences, Two Former Executives for Misleading Claims About Alzheimer’s Clinical Trial.www.sec.gov101 to News@lemmy.worldEnglish • 7 months agomessage-square0fedilink